Cancer Epidemiology represents the study of factors responsible for the initiation, metastasis and prognosis of various types of cancer. Epidemiological research findings on cancer can facilitate the formulation of suitable therapeutic treatment methods and preventive medicines for cancer.
Journal of Cancer Epidemiology & Prevention is a peer reviewed scholarly journal that focuses on the publication of research findings on the role of carcinogens and oncogenes in the manifestation of cancer. Manuscripts showcasing the adept cancer vaccines and their effectiveness in the prevention of cancer are solicited.
The scope of the journal includes cancer etiology, health disparities associated with cancer, screening and detection of cancers at an early stage with the help of biomarkers, cancer development and control and surveillance. The Journal of Cancer Epidemiology & Prevention also publishes novel findings in occupational epidemiology as well as genetic and molecular epidemiology of cancer including environmental carcinogens, gene-environment interactions and cancer risk prediction.
The Journal accepts original research article, review article, short communication, case report, letter-to-the-Editor and Editorials for publication in an open access platform. All the published articles can be accessed online without any subscription charges and will receive the benefit of extensive worldwide visibility.
Article processing will be done through the Editorial Manager System which helps in maintaining the quality of the peer review process and provides easy access to the authors to track the process of manuscript evaluation and publication in an automated way.
All the submitted manuscripts undergo peer review by the subject matter experts under the supervision of the Editor-in-Chief or assigned Editorial committee member of the Journal of Cancer Epidemiology and Prevention. Approval of at least two independent reviewers and the editor is mandatory for the acceptance of the manuscript for publication.
A biomarker may be a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. It can be used to see how well the body responds to a treatment for a disease or condition. Biomarkers of cancer include nucleic acids, proteins, sugars, lipids, and small metabolites, cytogenetic and cytokinetic parameters as well as whole tumor cells found in the body fluid. Genetic, epigenetic, proteomic, glycomic, and imaging biomarkers can be used for cancer diagnosis, prognosis, and epidemiology.
Related Journals of Cancer Biomarkers
Cancer Biomarkers, Biomarkers in Cancer, Cancer Epidemiology, Biomarkers & Prevention, Journal of Cancer, Cancer Causes & Control, Journal of Molecular Biomarkers & Diagnosis, Archives in Cancer Research
Cancer control can be done by reducing the number of cancer cases and deaths and improving quality of life of cancer patients, through the systematic and equitable implementation of evidence-based strategies for prevention, early detection, diagnosis, treatment, and palliation, making the best use of available resources.
Related Journals of Cancer Control
The fundamental abnormality resulting in the development of cancer is the continual unregulated proliferation of cancer cells. Cancer cells grow and divide in an uncontrolled manner rather than responding appropriately to the signals that control normal cell behavior, invading normal tissues and organs and eventually spreading throughout the body.
Related Journals of Cancer Development
Etiology is the study of causation, or origination. Cancer is neither contagious nor hereditary disease. It is suggested that every living organism has some inactive cancer-causing genes called proto-oncogenes. A number of physical, chemical or biological agents are known to mutate and activate these proto-oncogenes into active and cancer causing oncogenes. Due to altered gene activity, normal control mechanism is lost and the abnormal cell growth and cell division take place. Cancer can be caused by radiations, physical irritants and chemical or biological agents.
Related Journals of Cancer Etiology
The National Cancer Institute (NCI) defines "cancer health disparities" as adverse differences in cancer incidence (new cases), cancer prevalence (all existing cases), cancer death (mortality), cancer survivorship, and burden of cancer or related health conditions that exist among specific population groups in the United States. These population groups may be characterized by age, disability, education, ethnicity, gender, geographic location, income, or race. People who are poor, lack health insurance, and are medically underserved (have limited or no access to effective health care)-regardless of ethnic and racial background-often bear a greater burden of disease than the general population.
Related Journals of Cancer Health Disparities
A cancer incidence rate is the number of new cancers of a specific site/type occurring in a specified population during a year, usually expressed as the number of cancers per 100,000 population at risk. Cancer mortality is usually expressed as the number of deaths due to cancer per 100,000 population.
Related Journals of Cancer Incidence & Mortality
Cancer pharmacology plays a key role in drug development in cancer. It has adapted to the changing face of drug development by establishing experimental models and target orientated approaches. In silico approach ha helped to develop the field of cancer pharmacology.
Related Journals of Cancer Pharmacology
Cancer Chemotherapy and Pharmacology, Cancer Pharmacology, European Journal of Pharmacology, Journal of Pharmacology & Clinical Toxicology, Journal of Oncology Pharmacy Practice, International Journal of Basic & Clinical Pharmacology, Indian Journal of Pharmacology, Cancer Treatment Reviews, Cancer Treatment and Research Communications, Journal of Cancer Science & Therapy
Cancer prediction models provide an important approach to assessing risk and prognosis by identifying individuals at high risk, facilitating the design and planning of clinical cancer trials, fostering the development of benefit-risk indices, and enabling estimates of the population burden and cost of cancer. Models also may aid in the evaluation of treatments and interventions.
Related Journals of Cancer Risk Prediction
Checking for cancer (or for conditions that may become cancer) in people who have no symptoms is called screening. Regular screening for cancer detection is important to reduce the chance of dying with cancer.
Related Journals of Cancer Screening & Detection
Cancer surveillance is the ongoing, timely, and systematic collection and analysis of information on new cancer cases, extent of disease, screening tests, treatment, survival, and cancer deaths.
Related Journals of Cancer Surveillance
Cancer chemoprevention is the use of chemical substances to stop or keep cancer from developing. These substances may be natural, made in a laboratory, or taken from a living source. Chemoprevention is typically used by people who have a higher risk of developing cancer. People with a higher risk of cancer include those with an inherited cancer syndrome or a family history of cancer. It is also used to prevent relapsing of a cancer.
Related Journals of Cancer Chemoprevention
Cancer Chemotherapy and Pharmacology, Chemotherapy: Open Access, Journal of Chemotherapy, Journal of Cancer Therapy, American Journal of Cancer Therapy and Pharmacology, Advances in Cancer Prevention, Cancer Medicine & Anti-cancer Drugs
Cancer Molecular epidemiology is a branch of oncology and epidemiology that focuses on the contribution of potential environmental and genetic risk factors, identified at the molecular level, to the etiology, distribution and prevention of cancer within families and across populations. The goal of molecular epidemiology is to supplement and integrate existing methods.
Related Journals of Cancer Molecular Epidemiology
American Association for Cancer Research, Cancer Biomarkers, Biomarkers in Cancer, Cancer Epidemiology, Biomarkers & Prevention, Journal of Cancer, Cancer Causes & Control, Oncology & Cancer Case Reports
Radiotherapy is widely used for the treatment of cancer. It uses or waves, such as gamma rays, x-rays, electron beams, or protons, to damage or destroy the cancer cells. Radiation can be given alone or used with other treatments, such as surgery or chemotherapy.
Related Journals of Cancer Radiotherapy
Occupational epidemiology has been defined as the study of the effects of workplace exposures on the frequency and distribution of diseases and injuries in the population. The main objective of occupational epidemiology is prevention through identifying the consequences of workplace exposures on health.
Related Journals of Occupational Epidemiology
Prognosis of a cancer depends on many factors like person's medical history, type of cancer, stage of cancer, characteristics of the cancer, treatment chosen, response to treatment etc. The term "Five-year survival" is used while talking about cancer prognosis and survival.
Related Journals of Cancer Prognosis
Journal of Cancer, British Journal of Cancer, Archives in Cancer Research, Journal of Cancer Policy, Journal of Cancer Science & Therapy, CA: A Cancer Journal of Clinicians, Cancer Epidemiology, Cancer Causes & Control
Author(s): Ruggero Errante P, Menezes-Rodrigues FS, Alberto Andrade Leite, Afonso Caricati-Neto and Leandro Bueno Bergantin
Cell signaling is a crucial event for the survival and progress of normal cellular functions. However, mutations of certain genes can lead to the emerging of cancer cells, which can use these signalin ... Read More
Author(s): Yi-Lin Chen, Chia-Chi Lung, Jing-Yang Huang, Oswald Ndi Nfor, Pei-Chieh Ko, Yung-Po Liaw
Background The global incidence and mortality of liver diseases is increasing. One of the major risk factors for liver cancer is the presence of liver cirrhosis. Traditional Chinese medicines (TCM) a ... Read More
Author(s): Mohammed Ibrahim MD
Background: Disparities in the enrollment of minorities and elderly in cancer clinical trials have been reported in large national studies. We studied patient enrollment in clinical trials at William ... Read More
Author(s): Chhabra S and Gangane N
Introduction: Despite a long history of disease and great efforts in research, there is no practical and accurate system to know true precancerous lesions, so there is a limitation to prevention of en ... Read More
Author(s): Ruby Chang,Leah Greene and Kristine McCluskey
Our specimen worksheets act as teaching tools for our residents, fellows and pathologists’ assistant students and ultimately improve quality and efficiency within our anatomic pathology service. ... Read More
All Published work is licensed under a Creative Commons Attribution 4.0 International License
Copyright © 2018 All rights reserved. iMedPub LTD Last revised : June 23, 2018